Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$626M |
| 2 |
Warner Bros
WBD
|
+$447M |
| 3 |
Apple
AAPL
|
+$436M |
| 4 |
RTX Corp
RTX
|
+$434M |
| 5 |
Constellation Brands
STZ
|
+$320M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.13B |
| 2 |
Microsoft
MSFT
|
+$502M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$436M |
| 4 |
EXAS
Exact Sciences
EXAS
|
+$415M |
| 5 |
EA
Electronic Arts
EA
|
+$388M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.75% |
| 2 | Industrials | 9.36% |
| 3 | Consumer Discretionary | 8.52% |
| 4 | Healthcare | 7.75% |
| 5 | Financials | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Altria Group
MO
$114B
| $5.95M | 0.01% |
90,143
+51,507
| +133% | +$3.31M |
|
1227
Surrozen
SRZN
$275M
| $5.94M | 0.01% |
203,888
+13,399
| +7% | +$321K |
|
1228
Red Cat Holdings
RCAT
$1.39B
| $5.92M | 0.01% |
452,394
+425,385
| +1,575% | +$5.81M |
|
1229
Compass Therapeutics
CMPX
$456M
| $5.92M | 0.01% |
1,119,090
-474,185
| -30% | -$2.74M |
|
|
FRMI
1230
Fermi Inc
FRMI
$3.85B
| $5.92M | 0.01% |
1,013,614
-1,054,995
| -51% | -$9.23M |
|
1231
CALL
Cadence Design Systems
CDNS
$91.4B
| $5.92M | 0.01% |
21,300
+12,900
| +154% | +$3.85M |
|
1232
CALL
iShares US Home Construction ETF
ITB
$2.29B
| $5.91M | 0.01% |
65,300
+9,300
| +17% | +$952K |
|
|
OFRM
1233
Once Upon a Farm PBC
OFRM
$707M
| $5.91M | 0.01% |
+361,640
| New | +$7.44M |
|
1234
MDU Resources
MDU
$4.2B
| $5.91M | 0.01% |
+284,992
| New | +$5.84M |
|
1235
Bitdeer Technologies
BTDR
$3.07B
| $5.87M | 0.01% |
678,639
+638,679
| +1,598% | +$6.71M |
|
1236
PUT
CleanSpark
CLSK
$3.27B
| $5.87M | 0.01% |
689,700
+661,200
| +2,320% | +$7.07M |
|
1237
First Trust RBA American Industrial Renaissance ETF
AIRR
$9.76B
| $5.84M | 0.01% |
+52,700
| New | +$5.96M |
|
1238
Ameresco
AMRC
$1.17B
| $5.8M | 0.01% |
+227,505
| New | +$6.82M |
|
1239
CALL
Chevron
CVX
$392B
| $5.79M | 0.01% |
28,000
-78,800
| -74% | -$14.4M |
|
|
CRCL
1240
CALL
Circle Internet Group
CRCL
$23.4B
| $5.79M | 0.01% |
+60,700
| New | +$5.15M |
|
1241
CALL
W.W. Grainger
GWW
$61.3B
| $5.78M | 0.01% |
5,300
+4,400
| +489% | +$4.81M |
|
1242
PUT
Lamb Weston
LW
$7.61B
| $5.78M | 0.01% |
+136,800
| New | +$6.11M |
|
1243
CALL
Rocket Companies
RKT
$40.5B
| $5.78M | 0.01% |
405,600
-63,800
| -14% | -$1.16M |
|
1244
Zegna
ZGN
$3.66B
| $5.78M | 0.01% |
554,633
+418,475
| +307% | +$4.33M |
|
1245
CALL
Boeing
BA
$167B
| $5.77M | 0.01% |
29,000
-76,300
| -72% | -$17.4M |
|
1246
CALL
Vertiv
VRT
$98.5B
| $5.76M | 0.01% |
23,000
+6,700
| +41% | +$1.49M |
|
1247
CALL
iShares MSCI Brazil ETF
EWZ
$8.23B
| $5.76M | 0.01% |
150,000
-12,700
| -8% | -$464K |
|
1248
Pulse Biosciences
PLSE
$3.49B
| $5.72M | 0.01% |
+265,164
| New | +$4.89M |
|
1249
Palisade Bio
PALI
$361M
| $5.72M | 0.01% |
3,270,845
+2,945,478
| +905% | +$5.36M |
|
1250
Alcoa
AA
$13.5B
| $5.72M | 0.01% |
+86,211
| New | +$5.29M |
|
Similar funds
Dmitry Balyasny's Q1 2026 Portfolio in Review
As of Q1 2026, Dmitry Balyasny held 3,716 positions worth $77.1B, down 2.1% from $78.8B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Dmitry Balyasny withdrew a net $2.68B in Q1 2026, closing 911 positions and reducing 1,056 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $1.13B position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, down from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Dmitry Balyasny opened a new position in Silicon Laboratories worth $257M.
- Dmitry Balyasny's largest Q1 2026 buy was Silicon Laboratories: 1,233,893 shares worth $257M.
- Dmitry Balyasny added most to Meta Platforms (Facebook) in Q1 2026, an estimated $626M increase.
- Dmitry Balyasny's biggest Q1 2026 reduction was Microsoft, cutting an estimated $502M.
- Dmitry Balyasny fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $1.13B.
- Dmitry Balyasny's ten largest holdings make up 17% of its $77.1B portfolio in Q1 2026.
- Dmitry Balyasny opened 704 new positions and closed 911 in Q1 2026.
- Dmitry Balyasny's portfolio value fell 2.1% quarter-over-quarter to $77.1B.
Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.